ALMKT:EPA
Mauna Kea Technologies SA
0,091 €
arrow_downward
-0,33%(-0,00030) 1D
17 nën, 4:14:06 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,09 €
I lartë
0,09 €
I ulët
0,09 €
Kapitalizimi i tregut
17,99 mln
Vëllimi mesatar
478,35 mijë
Vëllimi
252,46 mijë
Raporti çmim/fitim
0,77
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Hap
0,09 €
I lartë
0,09 €
I ulët
0,09 €
Kapitalizimi i tregut
17,99 mln
Vëllimi mesatar
478,35 mijë
Vëllimi
252,46 mijë
Raporti çmim/fitim
0,77
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
TradingView
·
1 orë më parë
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 orë më parë
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
34 minuta më parë
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
Traders Union
·
1 orë më parë
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriHealth Care
IndustriaMedical device
Uebsajtimaunakeatech.com